Physician profile
Andrew Corr
NPI 1619958089
$626.50
in general payments reported to CMS, 2019-2025
15 companies · $97.79 in 2025
The $97.79 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.09 · 2021: $15.91 · 2022: $226 · 2023: $157 · 2024: $63.04 · 2025: $97.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $124.99 | 2022 | |
| Glaxosmithkline, LLC. | $67.02 | 2022-2023 | Shingrix, Arexvy |
| Irhythm Technologies, INC. | $62.45 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $51.68 | 2021-2024 | |
| Abiomed | $43.37 | 2023 | Impella |
| Shockwave Medical, INC | $42.67 | 2025 | |
| Abbvie INC. | $40.65 | 2022-2023 | Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $38.90 | 2019-2025 | Airsupra |
| Lilly USA, LLC | $28.58 | 2019-2025 | Mounjaro, Zepbound |
| Si-Bone, INC. | $27.97 | 2023 | |
| Janssen Pharmaceuticals, INC | $23.77 | 2019 | |
| Novo Nordisk INC | $22.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.50 | 2023 | |
| Novartis Pharmaceuticals Corporation | $15.93 | 2025 | |
| Merck Sharp & Dohme LLC | $15.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Corr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.